Market Closed -
Nasdaq Copenhagen
10:59:45 2024-04-26 am EDT
5-day change
1st Jan Change
863.4
DKK
-0.09%
-4.70%
+11.84%
Coloplast A/S : Voting results
December 02, 2021 at 12:11 pm EST
Coloplast A/S
Annual General Meeting 02 December 2021
No. of shares
Proportion of
Total No. of
No.
Item on the Agenda
for which valid
share capital
valid votes
votes have
%
been cast
Section101(5)(1)
Section101(5)(2)
Section101(5)(3)
No. of votes
%
No. of votes
%
No. of votes
%
FOR
AGAINST
ABSTAIN
Section101(5)(4)
Section101(5)(5)
2.
Presentation and approval of the audited annual report
143,130,781
66.26
305,130,781
304,109,256
99.67
116,371
0.04
905,154
0.30
3.
Resolution on the distribution of profit in accordance with the approved
143,130,781
66.26
305,130,781
301,690,890
98.87
87,634
0.03
3,352,257
1.10
annual report
4.
Presentation and approval of the remuneration report
143,130,781
66.26
305,130,781
293,667,409
96.24
4,918,021
1.61
6,545,351
2.15
5.
Approval of the Board of Directors' remuneration for the current
143,130,781
66.26
305,130,781
301,671,655
98.87
102,878
0.03
3,356,248
1.10
financial year
6.1
Update of remuneration policy
143,130,781
66.26
305,130,781
295,712,977
96.91
6,015,568
1.97
3,402,236
1.12
7. Election of members to the Board of Directors. The Board of Directors proposes election of the following members:
Lars Søren Rasmussen
143,130,781
66.26
305,130,781
279,839,132
91.71
0
0.00
25,291,649
8.29
Niels Peter Louis-Hansen
143,130,781
66.26
305,130,781
282,055,866
92.44
0
0.00
23,074,915
7.56
Jette Nygaard-Andersen
143,130,781
66.26
305,130,781
304,806,441
99.89
0
0.00
324,340
0.11
Carsten Hellmann
143,130,781
66.26
305,130,781
304,841,668
99.91
0
0.00
289,113
0.09
Marianne Wiinholt
143,130,781
66.26
305,130,781
290,417,716
95.18
0
0.00
14,713,065
4.82
Annette Brüls
143,130,781
66.26
305,130,781
305,037,686
99.97
0
0.00
93,095
0.03
8. Election of auditors
Re-election of PricewaterhouseCoopers Statsautoriseret
143,130,781
66.26
305,130,781
298,010,997
97.67
0
0.00
7,119,784
2.33
Revisionspartnerselskab as the company's auditors
Computershare Investor Services ©
Attachments
Original Link
Original Document
Permalink
Disclaimer
Coloplast A/S published this content on 02 December 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 02 December 2021 17:10:08 UTC .
Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024.
Feb. 26
CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat
Feb. 14
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders
Feb. 09
DJ
Global markets live: Tesco, Boeing, Roche, Exxon Mobil, PepsiCo...
Feb. 09
Transcript : Coloplast A/S, Q1 2024 Earnings Call, Feb 09, 2024
Feb. 09
European shares flat as higher yields counter earnings bump
Feb. 09
RE
European shares inch up on earnings bump, higher yields weigh
Feb. 09
RE
Coloplast Posts Growth in Fiscal Q1 Net Profit, Revenue
Feb. 09
MT
Coloplast Launches Peristeen Light for People with Bowel Disorders
Feb. 09
CI
Coloplast A/S Reports Earnings Results for the First Quarter Ended December 31, 2023
Feb. 09
CI
Coloplast A/S Reaffirms Earnings Guidance for the Fiscal Year 2023/24
Feb. 09
CI
Coloplast Rolls Out New Silicone Foam for Wound Care in US
Jan. 31
MT
Coloplast A/SLaunches Biatain® Silicone Fit for Pressure Injury Prevention and Wound Management in the US
Jan. 31
CI
Nordic Stocks Decreased Wednesday; Kone B Posted Biggest Loss
Jan. 17
DJ
COLOPLAST : EPS cut (2023: -12.9%, 2024: -14.7%)
Jan. 04
Coloplast A/S Approves the Distribution of Year-End Dividend
Dec. 07
CI
COLOPLAST : Q4 23: more misses than hits
Dec. 06
Sweden's Bactiguard Hires New CFO
Nov. 21
MT
Nordic Stocks Decreased Thursday; Okeanis Eco Tankers Took Biggest Hit
Nov. 09
DJ
Transcript : Coloplast A/S, 2023 Earnings Call, Nov 09, 2023
Nov. 09
European shares gain on earnings boost; investors await cues on policy outlook
Nov. 09
RE
Coloplast to Build EUR100 Million Intermittent Catheter Manufacturing Site in Portugal
Nov. 09
MT
Coloplast A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023
Nov. 09
CI
Coloplast Books Higher FY23 Net Profit; Revenue Jumps
Nov. 09
MT
Coloplast Announces New Manufacturing Site in Portugal
Nov. 09
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows:
- hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.;
- ostomy care products (36.8%): bags and equipment used following intestinal operations;
- wound care and skincare products (11.9%): wound dressings, bandages, creams and gels;
- voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc.
Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
More about the company
Last Close Price
863.4
DKK
Average target price
917.1
DKK
Spread / Average Target
+6.21%
Consensus
1st Jan change
Capi.
+11.84% 27.91B -32.98% 2.95B -15.97% 2.47B +11.90% 2.22B -1.11% 1.91B -13.37% 1.84B -7.78% 1.4B -0.38% 1.26B +13.51% 1.13B +4.01% 1.13B
Medical Supplies
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1